{"content":"<li class=\"n-box-item date-title\" data-end=\"1503028799\" data-start=\"1502942400\" data-txt=\"Monday, December 23, 2019\">Thursday, August 17, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3290337\" data-ts=\"1503022387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPN\" target=\"_blank\">CPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290337-wsj-calpine-near-takeout-energy-capital-partners-for-15_25-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Calpine near takeout by Energy Capital Partners for $15.25/share</a></h4><ul>     <li>Calpine (NYSE:<a href='https://seekingalpha.com/symbol/CPN' title='Calpine Corporation'>CPN</a>)&nbsp;<font color='green'>+9.2%</font>&nbsp;AH following a <em>WSJ</em> report that Energy Capital Partners is <a href=\"https://www.wsj.com/articles/energy-capital-partners-is-nearing-deal-to-buy-calpine-1503012422\" target=\"_blank\">near a deal to acquire</a> the power generating company for $15.25/share, which could be announced as soon as tomorrow.</li>     <li>The deal would value CPN at $5.5B; including debt, the enterprise value would be ~$17B.</li>     <li>CPN, which emerged from bankruptcy in 2008, has been cutting costs and selling off non-core assets as the company and its peers struggle with historically low natural gas prices.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290337\" data-linked=\"WSJ: Calpine near takeout by Energy Capital Partners for $15.25/share\" data-tweet=\"$CPN - WSJ: Calpine near takeout by Energy Capital Partners for $15.25/share https://seekingalpha.com/news/3290337-wsj-calpine-near-takeout-energy-capital-partners-for-15_25-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3290337-wsj-calpine-near-takeout-energy-capital-partners-for-15_25-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290335\" data-ts=\"1503013323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRL\" target=\"_blank\">CTRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290335-control4-up-4_4-on-move-s-and-p-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Control4 up 4.4% on move into S&amp;P SmallCap 600</a></h4><ul>   <li>Smart-home and business firm Control4 (<a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='red'>-3.9%</font>) is <font color='green'>up 4.4%</font> postmarket on word that it will <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/569753_control6.pdf?force_download=true\" target=\"_blank\">join the S&amp;P SmallCap 600</a>.</li>    <li>The move's effective prior to the market open on Tuesday.</li><li>The stock will replace that of Albany Molecular Research (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a>), since Albany's acquisition by Carlyle Group and GTCR is expected to close soon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290335\" data-linked=\"Control4 up 4.4% on move into S&amp;P SmallCap 600\" data-tweet=\"$CTRL $CTRL $AMRI - Control4 up 4.4% on move into S&amp;P SmallCap 600 https://seekingalpha.com/news/3290335-control4-up-4_4-on-move-s-and-p-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3290335-control4-up-4_4-on-move-s-and-p-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290334\" data-ts=\"1503012968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASYS\" target=\"_blank\">ASYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290334-amtech-systemsminus-4_2-on-news-of-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amtech Systems -4.2% on news of share offering</a></h4><ul>   <li>Amtech Systems (<a href=\"http://seekingalpha.com/symbol/ASYS\" target=\"_blank\">ASYS</a> <font color='red'>-4.8%</font>) is <font color='red'>off another 4.2%</font> after hours following the announcement it will <a href=\"https://seekingalpha.com/pr/16918947-amtech-announces-proposed-public-offering-common-stock\" target=\"_blank\">pursue a public offering</a> of common shares.</li>    <li>It's offered no details on terms so far. Net proceeds are set for general purposes, which could include working capital, capex or acquisitions.</li>    <li>Roth Capital Partners is the sole manager for the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290334\" data-linked=\"Amtech Systems -4.2% on news of share offering\" data-tweet=\"$ASYS - Amtech Systems -4.2% on news of share offering https://seekingalpha.com/news/3290334-amtech-systemsminus-4_2-on-news-of-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3290334-amtech-systemsminus-4_2-on-news-of-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290330\" data-ts=\"1503010697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTU\" target=\"_blank\">BTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290330-peabody-energy-to-repurchase-40m-of-stock-alongside-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peabody Energy to repurchase $40M of stock alongside secondary offering</a></h4><ul>     <li>Peabody Energy (NYSE:<a href='https://seekingalpha.com/symbol/BTU' title='Peabody Energy Corp.'>BTU</a>) <font color='red'>-1.9%</font>&nbsp;AH after announcing the launch of a 12.8M-share <a href=\"https://www.peabodyenergy.com/Media-Center/Newsroom\" target=\"_blank\">secondary offering</a> by certain selling stockholders affiliated with Discovery Capital Management; BTU will not receive any proceeds from the offering.</li>     <li>Alongside the offering, BTU says it will repurchase ~$40M worth of shares from the underwriter.</li>     <li>The shares offered were previously issued by BTU in connection with its emergence from Chapter 11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290330\" data-linked=\"Peabody Energy to repurchase $40M of stock alongside secondary offering\" data-tweet=\"$BTU - Peabody Energy to repurchase $40M of stock alongside secondary offering https://seekingalpha.com/news/3290330-peabody-energy-to-repurchase-40m-of-stock-alongside-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3290330-peabody-energy-to-repurchase-40m-of-stock-alongside-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290328\" data-ts=\"1503010161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290328-videogame-sales-up-19-growth-in-all-categories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame sales up 19% with growth in all categories</a></h4><ul>   <li>Videogame sales grew again in July with broad gains across all categories and continuing strength from hardware as consoles flexed their muscles.</li>    <li>Overall sales rose 19% Y/Y to $588M, according to NPD Group, and hardware spending rose 29% to $182M thanks to continuing early sales of the Nintendo Switch (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='red'>-1%</font>) as well as growth from PlayStation 4 (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-1%</font>).</li>    <li>Accessories spending rose 9% to $129M as a decline in interactive gaming toys slowed.</li>    <li>In software, spending rose 17% to $277M, paced by Nintendo's <i>Splatoon 2.</i> YTD sales are fractionally higher now, to $2.7B. Console/portable software rose 17% to $263M, while PC game software (physical and via Steam) rose 14% to $14M.</li>    <li>Behind <i>Splatoon 2</i> in the dollar sales chart: No. 2, <i>Crash Bandicoot: N. Sane Trilogy</i> (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='red'>-2.4%</font>); No. 3, <i>Grand Theft Auto V</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='red'>-1.2%</font>); No. 4, <i>Final Fantasy XII: The Zodiac Age</i> (Square Enix); No. 5, <i>The Legend of Zelda: Breath of the Wild</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>).</li>    <li>Rounding out the top 10 there: No. 6, <i>Injustice 2</i> (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='red'>-0.3%</font>); No. 7, <i>Mario Kart 8</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>); No. 8, <i>Overwatch</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>);<i> </i>No. 9,<i> Tom Clancy's Rainbow Six: Siege</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='red'>-0.6%</font>); and No. 10,&nbsp; <i>NBA 2K17</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>).</li>    <li>The Switch was the best-selling hardware platform for the month, while PlayStation 4 is the YTD leader.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290328\" data-linked=\"Videogame sales up 19% with growth in all categories\" data-tweet=\"$NTDOY $NTDOY $ATVI - Videogame sales up 19% with growth in all categories https://seekingalpha.com/news/3290328-videogame-sales-up-19-growth-in-all-categories?source=tweet\" data-url=\"https://seekingalpha.com/news/3290328-videogame-sales-up-19-growth-in-all-categories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290323\" data-ts=\"1503007111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWH\" target=\"_blank\">SPWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290323-sportsmans-warehouse-rallies-after-edging-past-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse rallies after edging past estimates</a></h4><ul><li>It's a relief rally for Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) after results come in ahead of expectations to take some of the edge off of Dick's harsh sector warning earlier this week.</li><li>As opposed to Dick's, SPWH held guidance steady at FY18 EPS of $0.60 to $0.66 vs. $0.62 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290278-sportsmans-warehouse-beats-0_02-beats-revenue\" target=\"_blank\">Sportsmans Warehouse beats by $0.02, beats on revenue</a> (Aug. 17)</li><li>Shares of Sportsman's Warehouse are&nbsp;<font color='green'>up 16.5%</font>&nbsp;AH to $4.03.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290323\" data-linked=\"Sportsman&#39;s Warehouse rallies after edging past estimates\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse rallies after edging past estimates https://seekingalpha.com/news/3290323-sportsmans-warehouse-rallies-after-edging-past-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3290323-sportsmans-warehouse-rallies-after-edging-past-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290322\" data-ts=\"1503006875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZOES\" target=\"_blank\">ZOES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290322-transactions-fall-off-zoes-kitchen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transactions fall off at Zoe&#39;s Kitchen</a></h4><ul><li>Zoe's Kitchen (NYSE:<a href='https://seekingalpha.com/symbol/ZOES' title='Zoe&#39;s Kitchen'>ZOES</a>)&nbsp;reports a break-even Q2 on sales just a touch short of analyst estimates.</li><li>Comparable restaurants sales trailed off 3.8% during the quarter. Transactions were down 5.0%.</li><li>Restaurant contribution margin plunged 260 bps Y/Y to 19.0%.</li><li>Looking ahead, Zoe's sees FY17 revenue of $314M to $322M vs. $317M consensus.</li><li>ZOES&nbsp;<font color='red'>-2.03%</font>&nbsp;AH to $13.01.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290322\" data-linked=\"Transactions fall off at Zoe&#39;s Kitchen\" data-tweet=\"$ZOES - Transactions fall off at Zoe&#39;s Kitchen https://seekingalpha.com/news/3290322-transactions-fall-off-zoes-kitchen?source=tweet\" data-url=\"https://seekingalpha.com/news/3290322-transactions-fall-off-zoes-kitchen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290321\" data-ts=\"1503005873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290321-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='green'>+15.0%</font>. <a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a> <font color='green'>+10.8%</font>. <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='green'>+6.1%</font>. <a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='green'>+3.9%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+3.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='red'>-5.4%</font>. <a href='https://seekingalpha.com/symbol/HIBB' title='Hibbett Sports, Inc.'>HIBB</a> <font color='red'>-4.4%</font>. <a href='https://seekingalpha.com/symbol/TVIX' title='VelocityShares Daily 2x VIX Short-Term ETN'>TVIX</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290321\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SPWH $ROST $GPS - After Hours Gainers / Losers https://seekingalpha.com/news/3290321-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3290321-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290320\" data-ts=\"1503005648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290320-gapplus-6-on-q2-earnings-beat-upside-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap +6% on Q2 earnings beat, upside full-year guidance</a></h4><ul>     <li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>) <font color='green'>+6.4%</font>&nbsp;AH after reporting <a href=\"https://seekingalpha.com/news/3290287-gap-beats-0_06-beats-revenue\" target=\"_blank\">Q2 earnings</a> that more than doubled year-ago results while beating Wall Street expectations, and raising its 2017 earnings outlook.</li>     <li>GPS now sees FY 2017 EPS of $2.02-$2.10, above the $2.00 analyst consensus estimate and the company's earlier guidance of $1.95-$2.05.</li>     <li>For Q2, overall same-store sales rose 1% vs. a 2% decline in the year-ago period, while analysts were expecting sales to come in flat Y/Y; it was the company's third consecutive quarter of <a href=\"http://www.reuters.com/article/us-gap-results-idUSKCN1AX2M4?il=0\" target=\"_blank\">higher comparable sales</a>.</li>     <li>By global brand, Old Navy comp sales climbed 5% vs. flat a year ago, Gap brand fell 1% vs. a 3% decline last year, and Banana Republic fell 5% vs. a 9% drop a year ago.</li>     <li>Q2 adjusted operating margin was 10.2% compared  with 11.1% in the same period last year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290320\" data-linked=\"Gap +6% on Q2 earnings beat, upside full-year guidance\" data-tweet=\"$GPS - Gap +6% on Q2 earnings beat, upside full-year guidance https://seekingalpha.com/news/3290320-gapplus-6-on-q2-earnings-beat-upside-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3290320-gapplus-6-on-q2-earnings-beat-upside-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290309\" data-ts=\"1503003103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNAT\" target=\"_blank\">CNAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290309-conatus-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus files for $100M mixed shelf offering; shares down 3% after hours</a></h4><ul><li>Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/1383701/000119312517261015/d432974ds3.htm\" target=\"_blank\">files </a>an S-3 with the SEC for a $100M mixed shelf offering of common and preferred stock, debt, warrants and units. A prospectus specific to the subsequent offering(s) will be available when planned.</li><li>Shares are off&nbsp;<font color='red'>3%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290309\" data-linked=\"Conatus files for $100M mixed shelf offering; shares down 3% after hours\" data-tweet=\"$CNAT - Conatus files for $100M mixed shelf offering; shares down 3% after hours https://seekingalpha.com/news/3290309-conatus-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3290309-conatus-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290305\" data-ts=\"1503002521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290305-hulu-live-offering-reaches-201-local-stations-fox-additions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hulu live offering reaches 201 local stations with Fox additions</a></h4><ul>   <li>Hulu has <a href=\"http://www.multichannel.com/news/content/hulu-tacks-three-fox-affiliates/414687\" target=\"_blank\">added three Fox affiliates</a> to its live streaming TV service.</li>    <li>Joining the local offerings are Raycom's WVUE in New Orleans, and a pair of Tribune Media (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='green'>+0.3%</font>) stations: WTIC in Hartford/New Haven, and WJW in Cleveland-Akron.</li>    <li>That brings the list of live channels available via Hulu's service (<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a> <font color='red'>-0.8%</font>, <a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-2.4%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-2.3%</font>, <a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a> <font color='red'>-0.3%</font>) to 201.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290305\" data-linked=\"Hulu live offering reaches 201 local stations with Fox additions\" data-tweet=\"$CMCSA $CMCSA $DIS - Hulu live offering reaches 201 local stations with Fox additions https://seekingalpha.com/news/3290305-hulu-live-offering-reaches-201-local-stations-fox-additions?source=tweet\" data-url=\"https://seekingalpha.com/news/3290305-hulu-live-offering-reaches-201-local-stations-fox-additions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290291\" data-ts=\"1503001397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290291-applied-materials-beats-q2-estimates-semiconductor-sales-up-42-sharesplus-2_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Materials beats Q2 estimates, semiconductor sales up 42%; shares +2.6%</a></h4><ul><li>        Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) reports Q2 results with earnings and revenue beats with year-over-year sales growth of nearly 33%.</li><li>        Segment sales: Semiconductor Systems, $2.5B (+42%Y/Y); Applied Global Services, $786M (+20%); Display and Adjacent Markets, $410M (+31%).</li><li>               Gross margin rose 2.9 points on the year to 46.6%. Operating margin grew 5.9 points to 28.7%.&nbsp;</li><li>               Applied Materials generated $1.37B in cash from operations, returning $482M to shareholders. The company ended the quarter with $5.3B in cash and equivalents. &nbsp;&nbsp;</li><li>               Q4 outlook: net sales, $3.85B to $4B (consensus: $3.71B); EPS, $0.86 to $0.94 (consensus: $0.82).&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16918807-applied-materials-delivers-best-quarter-50-year-history\" target=\"_blank\">Press release</a>&nbsp;</li><li>                  Applied Materials shares are&nbsp;<font color='green'>up 2.57%</font>&nbsp;aftermarket. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3290270-applied-materials-beats-0_02-beats-revenue\" target=\"_blank\">Applied Materials beats by $0.02, beats on revenue</a> (Aug. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290291\" data-linked=\"Applied Materials beats Q2 estimates, semiconductor sales up 42%; shares +2.6%\" data-tweet=\"$AMAT - Applied Materials beats Q2 estimates, semiconductor sales up 42%; shares +2.6% https://seekingalpha.com/news/3290291-applied-materials-beats-q2-estimates-semiconductor-sales-up-42-sharesplus-2_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3290291-applied-materials-beats-q2-estimates-semiconductor-sales-up-42-sharesplus-2_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290287\" data-ts=\"1503001000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPS\" target=\"_blank\">GPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290287-gap-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gap beats by $0.06, beats on revenue</a></h4><ul><li>Gap (NYSE:<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a>): Q2 EPS of $0.58 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $3.8B (-1.3% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+12%</font>.</li><li><a href='https://seekingalpha.com/pr/16918852-gap-inc-reports-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3290287\" data-linked=\"Gap beats by $0.06, beats on revenue\" data-tweet=\"$GPS - Gap beats by $0.06, beats on revenue https://seekingalpha.com/news/3290287-gap-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3290287-gap-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290279\" data-ts=\"1503000529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290279-ross-stores-flies-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores flies after earnings topper</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>) reports comparable sales rose 4.0% in Q2 to almost double the 2.2% pace expected by analysts.</li><li>Operating margin came in at 14.9% of sales for the quarter, leading to a comfortable profit beat.</li><li>Looking ahead, the company expects Q3 EPS of $0.64 to $0.67 vs. $0.67 consensus and Q4 EPS of $0.88 to $0.92 vs. $0.91 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290271-ross-stores-beats-0_05-beats-revenue\" target=\"_blank\">Ross Stores beats by $0.05, beats on revenue</a> (Aug. 17)</li><li>ROST&nbsp;<font color='green'>+10.86%</font>&nbsp;AH to $59.12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290279\" data-linked=\"Ross Stores flies after earnings topper\" data-tweet=\"$ROST - Ross Stores flies after earnings topper https://seekingalpha.com/news/3290279-ross-stores-flies-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3290279-ross-stores-flies-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290271\" data-ts=\"1503000166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROST\" target=\"_blank\">ROST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290271-ross-stores-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ross Stores beats by $0.05, beats on revenue</a></h4><ul><li>Ross Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a>): Q2 EPS of $0.82 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $3.43B (+7.9% Y/Y) <font color='green'>beats by $60M</font>.</li><li>Shares <font color='green'>+4.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16918799-ross-stores-reports-second-quarter-earnings-issues-second-half-2017-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3290271\" data-linked=\"Ross Stores beats by $0.05, beats on revenue\" data-tweet=\"$ROST - Ross Stores beats by $0.05, beats on revenue https://seekingalpha.com/news/3290271-ross-stores-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3290271-ross-stores-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290267\" data-ts=\"1502999813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWX\" target=\"_blank\">TWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290267-wsj-and-t-hitting-time-warner-deal-milestone-in-talks-doj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: AT&amp;T hitting Time Warner deal milestone in talks with DOJ</a></h4><ul>   <li>AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-1.5%</font>) lawyers are talking with the Justice Department about terms of its $85B takeover of Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>), <i>The Wall Street Journal</i> reports -- <a href=\"https://www.wsj.com/articles/trump-threatened-to-kill-the-at-t-time-warner-deal-but-its-very-much-alive-1502998077\" target=\"_blank\">hitting a key milestone</a> suggesting the deal's success is imminent.</li>    <li>Time Warner shares, <font color='red'>down as much as 0.7%</font> earlier, have jumped back to the flat line.</li>    <li>Talks are progressing despite the lack of an antitrust chief at the department; the Senate adjourned for its August recess <a href=\"https://seekingalpha.com/news/3286034-report-t-seeking-bewkes-replacement-outside\" target=\"_blank\">without confirming Makan Delrahim</a> for the position. The Senate returns Sept. 5.</li>    <li>It also suggests that much-publicized opposition to the deal from candidate and President Trump might not endanger the deal after all.</li>    <li>And the deal-risk gap has narrowed to about 5% difference between Time Warner's share price and AT&amp;T's offer value, from about 20% when the deal was announced last fall.</li>    <li>The government is examining issues including AT&amp;T's treatment of content makers that compete with Time Warner, and its control of customer data.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290267\" data-linked=\"WSJ: AT&amp;T hitting Time Warner deal milestone in talks with DOJ\" data-tweet=\"$TWX $TWX $T - WSJ: AT&amp;T hitting Time Warner deal milestone in talks with DOJ https://seekingalpha.com/news/3290267-wsj-and-t-hitting-time-warner-deal-milestone-in-talks-doj?source=tweet\" data-url=\"https://seekingalpha.com/news/3290267-wsj-and-t-hitting-time-warner-deal-milestone-in-talks-doj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290266\" data-ts=\"1502999360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITW\" target=\"_blank\">ITW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290266-jpm-downgrades-illinois-tool-eaton-upgrades-kennametal-manitowoc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPM downgrades Illinois Tool, Eaton; upgrades Kennametal, Manitowoc</a></h4><ul>     <li>Illinois Tool Works (<a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a> <font color='red'>-2.7%</font>) and Eaton (<a href='https://seekingalpha.com/symbol/ETN' title='Eaton Corp. plc'>ETN</a> <font color='red'>-1.3%</font>) are lower after J.P. Morgan <a href=\"http://thefly.com/thestreet/realmoney/index.php/ITWid2597716/ITW-Illinois-Tool-Works-downgraded-to-Underweight-from-Neutral-at-JPMorgan\" target=\"_blank\">downgrades</a> shares of both companies to Underweight from Neutral, citing valuation and expectations for continued multiple compression on weaker than peer organic growth.</li>     <li>The firm trims its stock price target for ITW to $132 from $141 and for ETN to $70 from $73.</li>     <li>At the same time, JPM <a href=\"http://thefly.com/thestreet/realmoney/index.php/KMTid2597720/KMT-Kennametal-upgraded-to-Overweight-from-Neutral-at-JPMorgan\" target=\"_blank\">upgrades</a> Kennametal (<a href='https://seekingalpha.com/symbol/KMT' title='Kennametal Inc.'>KMT</a> <font color='red'>-0.8%</font>) to Overweight from Neutral, as the recent pullback offers an opportunistic entry points and company's FY 2018 guidance sets a low bar for the new CEO, and <a href=\"http://thefly.com/thestreet/realmoney/index.php/MTWid2597724/MTW-Manitowoc-upgraded-to-Neutral-from-Underweight-at-JPMorgan\" target=\"_blank\">upgrades</a> Manitowoc (<a href='https://seekingalpha.com/symbol/MTW' title='Manitowoc Company, Inc.'>MTW</a> <font color='red'>-0.3%</font>) to Neutral from Underweight, saying MTW's \"solid backlog\" balances out the risk to its outlook.</li>     <li>The firm raises its price target for KMT to $43 from $40 and for MTW to $7 from $6.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290266\" data-linked=\"JPM downgrades Illinois Tool, Eaton; upgrades Kennametal, Manitowoc\" data-tweet=\"$ITW $ITW $ETN - JPM downgrades Illinois Tool, Eaton; upgrades Kennametal, Manitowoc https://seekingalpha.com/news/3290266-jpm-downgrades-illinois-tool-eaton-upgrades-kennametal-manitowoc?source=tweet\" data-url=\"https://seekingalpha.com/news/3290266-jpm-downgrades-illinois-tool-eaton-upgrades-kennametal-manitowoc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290265\" data-ts=\"1502998963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290265-10-year-treasury-yield-back-near-years-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">10-year Treasury yield back near year&#39;s low</a></h4><ul><li>This just in: The 10-year Treasury yield has sunk back below 2.20%. Helping the 10-year note's three basis point decline today is a 1%+ swoon in the major indices and some dovish Fed-speak.</li><li>The 10-year started the year at around 2.45% - a couple of rate hikes and nearly 2K Dow points later, it's at 2.19%. Go figure.</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='green'>+0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='red'>-1.4%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3290265\" data-linked=\"10-year Treasury yield back near year&#39;s low\" data-tweet=\"$TLT $TBT $TMV - 10-year Treasury yield back near year&#39;s low https://seekingalpha.com/news/3290265-10-year-treasury-yield-back-near-years-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3290265-10-year-treasury-yield-back-near-years-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290260\" data-ts=\"1502996512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290260-70b-in-cash-cisco-still-looking-for-repatriation-holiday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">With $70B in cash, Cisco still looking for repatriation holiday</a></h4><ul>     <li>Current political/business firestorms aside, Cisco Systems (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='red'>-4.3%</font>) is still <a href=\"http://www.marketwatch.com/story/cisco-remains-optimistic-about-repatriation-holiday-possibly-next-year-2017-08-16\" target=\"_blank\">looking toward a potential repatriation holiday</a> that would let it bring home tens of billions of dollars in cash.</li>     <li>&ldquo;More people are saying it will happen in '18,&rdquo; Cisco CFO Kelly Kramer tells Therese Poletti. &ldquo;The good thing is that Democrats and Republicans are in agreement on this. I am optimistic.&rdquo;</li>     <li>Shares are down today after the company unsurprisingly reported <a href=\"https://seekingalpha.com/news/3289969-cisco-minus-1_2-percent-q4-earnings-beat-shows-declining-sales-profits\" target=\"_blank\">declining revenues and profits</a> amid higher expenses for memory chips. The company also nodded to its mix shift by <a href=\"https://seekingalpha.com/news/3290019-cisco-realigning-revenue-categories-model-evolves\" target=\"_blank\">redefining reported revenue categories</a> for the future.</li>     <li>Cisco has $70B in cash, but only $3B of that is in the United States. Kramer says the company has flexibility to cover dividends and buybacks without repatriating cash for now.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290260\" data-linked=\"With $70B in cash, Cisco still looking for repatriation holiday\" data-tweet=\"$CSCO - With $70B in cash, Cisco still looking for repatriation holiday https://seekingalpha.com/news/3290260-70b-in-cash-cisco-still-looking-for-repatriation-holiday?source=tweet\" data-url=\"https://seekingalpha.com/news/3290260-70b-in-cash-cisco-still-looking-for-repatriation-holiday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290258\" data-ts=\"1502996232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAR\" target=\"_blank\">CAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290258-bets-on-used-car-prices-add-volatility-on-avis-and-hertz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bets on used car prices add volatility on Avis and Hertz</a></h4><ul>     <li>The rapid fall and then partial recovery in Avis Budget (<a href='https://seekingalpha.com/symbol/CAR' title='Avis Budget Group, Inc.'>CAR</a> <font color='red'>-1.6%</font>) and Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-1.4%</font>) is tied to investors searching for an <a href=\"http://www.barrons.com/articles/hertz-theres-no-such-thing-as-a-one-way-trade-1502984994\" target=\"_blank\">investment vehicle</a> to place bets on used car prices, reasons Morgan Stanley's Adam Jonas.</li>     <li>\"For an investor who wants to express a negative view on used car values and/or the health of the auto ABS market, there is a dearth of instruments with which to express such a view,\" he writes.</li><li>\"The 2 US publicly traded car rental firms were seen as easy targets, particularly HTZ given its well-known operational issues, elevated debt levels, and debt maturity profile.\"</li>     <li>After rallying sharply since their June lows, Avis is now down 9% YTD&nbsp;and Hertz is off 12% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290258\" data-linked=\"Bets on used car prices add volatility on Avis and Hertz\" data-tweet=\"$CAR $CAR $HTZ - Bets on used car prices add volatility on Avis and Hertz https://seekingalpha.com/news/3290258-bets-on-used-car-prices-add-volatility-on-avis-and-hertz?source=tweet\" data-url=\"https://seekingalpha.com/news/3290258-bets-on-used-car-prices-add-volatility-on-avis-and-hertz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290256\" data-ts=\"1502995535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290256-technology-top-gainers-losers-of-2-45-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:45 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IMMR' title='Immersion Corporation'>IMMR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ISNS' title='Image Sensing Systems, Inc.'>ISNS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/DAIO' title='Data I/O Corporation'>DAIO</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RDCM' title='Radcom Ltd.'>RDCM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CSLT' title='Castlight Health, Inc.'>CSLT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AKTS' title='Akoustis Technologies, Inc.'>AKTS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/QTM-OLD' title='Quantum Corporation'>QTM-OLD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290256\" data-linked=\"Technology - Top Gainers / Losers as of 2:45 pm\" data-tweet=\"$IPDN $TCCO $IMMR - Technology - Top Gainers / Losers as of 2:45 pm https://seekingalpha.com/news/3290256-technology-top-gainers-losers-of-2-45-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3290256-technology-top-gainers-losers-of-2-45-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290255\" data-ts=\"1502995217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBF\" target=\"_blank\">PBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290255-reuters-bank-jitters-over-venezuela-stall-oil-delivery-to-pbf-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Bank jitters over Venezuela stall oil delivery to PBF Energy</a></h4><ul>     <li>A tanker carrying a cargo of ~1M barrels of Venezuelan heavy crude intended for refiner PBF&nbsp;Energy (<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy'>PBF</a> <font color='red'>-3.5%</font>) has been <a href=\"http://www.reuters.com/article/us-venezuela-oil-cargo-exclusive-idUSKCN1AX2AA?il=0\" target=\"_blank\">stranded for more than a month</a> off the Louisiana coast because no bank will deliver a letter of credit to discharge the oil, Reuters reports.</li>     <li>The tanker's fate is the latest example of Venezuelan state-run oil company PDVSA's precarious financial position amid political upheaval in the country.</li>     <li>It is not known which banks have denied letters of credit or if other U.S. refiners are affected.</li>     <li>PBF and PDVSA have a long-term supply agreement for Venezuelan oil signed in 2015 when PBF bought the Chalmette refinery from PDVSA and Exxon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290255\" data-linked=\"Reuters: Bank jitters over Venezuela stall oil delivery to PBF Energy\" data-tweet=\"$PBF - Reuters: Bank jitters over Venezuela stall oil delivery to PBF Energy https://seekingalpha.com/news/3290255-reuters-bank-jitters-over-venezuela-stall-oil-delivery-to-pbf-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3290255-reuters-bank-jitters-over-venezuela-stall-oil-delivery-to-pbf-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290254\" data-ts=\"1502995193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWS\" target=\"_blank\">NWS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290254-foxtel-fox-sports-australia-to-merge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foxtel, Fox Sports Australia to merge</a></h4><ul>   <li>Telstra (<a href=\"http://seekingalpha.com/symbol/TLSYY\" target=\"_blank\">TLSYY</a> <font color='red'>-9.5%</font>) and News Corp. (<a href='https://seekingalpha.com/symbol/NWS' title='News Corporation'>NWS</a> <font color='green'>+1.2%</font>, <a href='https://seekingalpha.com/symbol/NWSA' title='News Corporation'>NWSA</a> <font color='green'>+1.1%</font>) are merging their (jointly owned) Australian pay TV channel <a href=\"https://www.wsj.com/articles/foxtel-fox-sports-australia-to-merge-1502993932\" target=\"_blank\">Foxtel with Fox Sports Australia</a>.</li>    <li>The result would be a dominant outlet that would be 65% controlled by News Corp. and 35% by Telstra, and which could eventually pursue an initial public offering.</li>    <li>With regulatory approvals, the deal could be completed in the first half of next year.</li>    <li>News Corp. says not only would the combination strengthen the company in case of an IPO, it allows it to diversify its financials amid a secular decline in print advertising.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290254\" data-linked=\"Foxtel, Fox Sports Australia to merge\" data-tweet=\"$NWS $NWS $NWSA - Foxtel, Fox Sports Australia to merge https://seekingalpha.com/news/3290254-foxtel-fox-sports-australia-to-merge?source=tweet\" data-url=\"https://seekingalpha.com/news/3290254-foxtel-fox-sports-australia-to-merge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290252\" data-ts=\"1502994391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMY\" target=\"_blank\">HMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290252-harmony-goldplus-3-full-year-headline-earnings-jump-35\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmony Gold +3% as full-year headline earnings jump 35%</a></h4><ul>     <li>Harmony Gold (<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+2.9%</font>) is higher after reporting a 35% Y/Y increase in <a href=\"https://seekingalpha.com/news/3290053-harmony-gold-mining-reports-fy-results\" target=\"_blank\">FY 2017 profit</a> and saying it will <a href=\"http://www.nasdaq.com/article/safricas-harmony-gold-eyes-acquisitions-after-fy-earnings-rise-20170817-00676\" target=\"_blank\">consider exploration and acquisitions</a> to meet its 2019 production target of 1.5M oz.</li>     <li>HMY says it already has reached gold output of 1.09M oz. by the end of FY 2017 through its South African production, plant and tailings projects and its Hidden Valley acquisition.</li>     <li>HMY says headline EPS, which strips out certain one-off items, rose to 2.98 rand ($0.23) for the full year to June 30, from 2.21 rand a year earlier, but results were stung by a 917M rand provision for a possible settlement with miners who contracted lung diseases at work and impairments from certain mining operations.</li>     <li>Full-year revenue rose 5% to 19.3B as Y/Y production remained stable and helped by 728M rand in realized gains from gold hedges.</li>     <li>HMY also announces a final dividend of $0.35/share for the full year, up 70% Y/Y.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290252\" data-linked=\"Harmony Gold +3% as full-year headline earnings jump 35%\" data-tweet=\"$HMY - Harmony Gold +3% as full-year headline earnings jump 35% https://seekingalpha.com/news/3290252-harmony-goldplus-3-full-year-headline-earnings-jump-35?source=tweet\" data-url=\"https://seekingalpha.com/news/3290252-harmony-goldplus-3-full-year-headline-earnings-jump-35\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290249\" data-ts=\"1502992981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADP\" target=\"_blank\">ADP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290249-investor-chapman-lines-up-against-ackman-again-adp-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investor Chapman lines up against Ackman again, with ADP short</a></h4><ul>   <li>Robert Chapman loves being on the opposite side of a Bill Ackman trade, and he's at it again, telling CNBC he's <a href=\"https://www.cnbc.com/2017/08/17/short-seller-robert-chapman-battles-bill-ackman-again-bets-against-adp.html\" target=\"_blank\">short Automatic Data Processing</a>.</li>    <li><a href='https://seekingalpha.com/symbol/ADP' title='Automatic Data Processing, Inc.'>ADP</a> is <font color='red'>down 4.7%</font> to $105.93 after Ackman's webcast today laying out ADP's many challenges and growth levers (and a plan to more than double the stock in four years); Chapman says he shorted at an average of $119.50.</li>    <li>Ackman's webcast follows his taking an 8% stake and nominating three directors to the board amid a contentious battle with CEO Carlos Rodriguez.</li>    <li>\"Making a dollar being short an Ackman stock feels as good as making $10 on one that he is not long,\" Chapman told CNBC. Chapman had criticized Ackman four years ago over his Herbalife short and said Ackman would have a difficult time exiting.</li>    <li>With ADP, he argues that Ackman is focusing on quantity over quality of research. \"Where are we in the employment cycle? ... The payroll numbers have been expanding for 7 or 8 years ... The competition is fierce now.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290196-adp-minus-2_9-percent-ackman-lays-investment-case-webcast\" target=\"_blank\">ADP -2.9% as Ackman lays out investment case in webcast</a> (Aug. 17 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289070-ackman-filing-works-defuse-tension-adp-question-ceos-take\" target=\"_blank\">Ackman filing works to defuse tension with ADP, question CEO's take</a> (Aug. 14 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3288244-adp-ceo-rodriguez-ackman-reminds-spoiled-brat\" target=\"_blank\">ADP CEO Rodriguez: Ackman reminds of 'spoiled brat'</a> (Aug. 10 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290249\" data-linked=\"Investor Chapman lines up against Ackman again, with ADP short\" data-tweet=\"$ADP - Investor Chapman lines up against Ackman again, with ADP short https://seekingalpha.com/news/3290249-investor-chapman-lines-up-against-ackman-again-adp-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3290249-investor-chapman-lines-up-against-ackman-again-adp-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290247\" data-ts=\"1502992890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290247-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ESES' title='Eco-Stim Energy Solutions, Inc.'>ESES</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290247\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$SDLPF $TANH $CDXC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3290247-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3290247-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290244\" data-ts=\"1502992132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290244-fda-oks-expanded-use-for-astrazenecas-lynparza\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs expanded use for AstraZeneca&#39;s Lynparza</a></h4><ul><li>The FDA approves the use of AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='red'>-0.2%</font>) Lynparza (olaparib) for the second-line maintenance treatment of ovarian cancer that is responsive to platinum-based chemo. It was originally approved in the U.S. for advanced ovarian cancer in patients who have received at least three prior lines of chemo.</li><li>Ovarian cancer competitor Clovis Oncology (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='red'>-5.5%</font>) is under pressure from Lynparza's potential encroachment on Rubraca (rucaparib), approved for patients who have received at least two prior lines of chemo.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3290244\" data-linked=\"FDA OKs expanded use for AstraZeneca&#39;s Lynparza\" data-tweet=\"$AZN $AZN $CLVS - FDA OKs expanded use for AstraZeneca&#39;s Lynparza https://seekingalpha.com/news/3290244-fda-oks-expanded-use-for-astrazenecas-lynparza?source=tweet\" data-url=\"https://seekingalpha.com/news/3290244-fda-oks-expanded-use-for-astrazenecas-lynparza\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290242\" data-ts=\"1502991796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHIP\" target=\"_blank\">SHIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290242-seanergy-maritime-breaks-out-who-called\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seanergy Maritime breaks out, here&#39;s who called it</a></h4><ul><li>Seanergy Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a>) is&nbsp;<font color='green'>up 13.5%</font>&nbsp;on strong volume in a breakout called yesterday in a Marketplace trading alert from J Mintzmyer's <a href=\"https://seekingalpha.com/author/j-mintzmyer/research\" target=\"_blank\">Value Investor Edge</a>.</li><li>Mintzmyer believes that the high level of capesize bulker rates could push shares of SHIP to as high as $1.50. The volatile stock has ranged from $0.58 to $8.65 over the last 52 weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290242\" data-linked=\"Seanergy Maritime breaks out, here&#39;s who called it\" data-tweet=\"$SHIP - Seanergy Maritime breaks out, here&#39;s who called it https://seekingalpha.com/news/3290242-seanergy-maritime-breaks-out-who-called?source=tweet\" data-url=\"https://seekingalpha.com/news/3290242-seanergy-maritime-breaks-out-who-called\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290231\" data-ts=\"1502989216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290231-biogen-leads-ms-drug-firms-retreat-on-house-committees-price-inquiry-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen leads MS drug firms retreat on House Committee&#39;s price inquiry, shares down 3%</a></h4><ul><li>The market's selloff notwithstanding, Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-2.9%</font>) is taking it on the chin after a U.S. House of Representatives committee initiated an investigation into price hikes for drugs to treat multiple sclerosis &#40;MS&#41;.</li><li>Of the seven firms contacted, Biogen has the largest exposure to the MS arena, accounting for more than 88% of its Q2 product sales ($2,336M/2,640M).</li><li>Teva's Copaxone accounted for almost half of its Q2 specialty drug sales ($1,023M/2,065M) but less than 18% of its total product sales ($1,023M/5,686).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290217-house-dems-look-ms-med-prices-seven-drug-makers-contacted\" target=\"_blank\">House Dems look into MS med prices, seven drug makers contacted</a> (Aug. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290231\" data-linked=\"Biogen leads MS drug firms retreat on House Committee&#39;s price inquiry, shares down 3%\" data-tweet=\"$BIIB - Biogen leads MS drug firms retreat on House Committee&#39;s price inquiry, shares down 3% https://seekingalpha.com/news/3290231-biogen-leads-ms-drug-firms-retreat-on-house-committees-price-inquiry-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3290231-biogen-leads-ms-drug-firms-retreat-on-house-committees-price-inquiry-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290229\" data-ts=\"1502988441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290229-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/MYOV' title='Myovant Sciences'>MYOV</a> <font color='green'>+21%</font>. &nbsp;<a href='https://seekingalpha.com/symbol/CDTI' title='Clean Diesel Technologies, Inc.'>OTC:CDTI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='green'>+18%</font>.<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a>&nbsp;<font color='green'>+13%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+12%</font>. &nbsp;</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RAVE' title='RAVE Restaurant Group, Inc.'>RAVE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TIK' title='Tel-Instrument Electronics Corp'>TIK</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics'>PRQR</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290229\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SPEX $SSI $DCTH - Midday Gainers / Losers https://seekingalpha.com/news/3290229-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3290229-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290223\" data-ts=\"1502987309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290223-nasdaqs-1-decline-leads-averages-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq&#39;s 1% decline leads averages lower</a></h4><ul><li><font color='red'>Down 1.1%</font>&nbsp;just past noon, the Nasdaq has touched a session low. The S&amp;P 500 is&nbsp;<font color='red'>off 0.8%</font>&nbsp;and Dow&nbsp;<font color='red'>0.6%</font>.</li><li>Leading tech lower is Cisco's&nbsp;<font color='red'>3.8% post-earnings drop</font>.</li><li>Stocks in Europe are lower as well, with the Stoxx 600&nbsp;<font color='red'>losing 0.6%</font>.</li><li>The 10-year Treasury yield is down by 1.7 basis points to 2.209%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290223\" data-linked=\"Nasdaq&#39;s 1% decline leads averages lower\" data-tweet=\"Nasdaq&#39;s 1% decline leads averages lower https://seekingalpha.com/news/3290223-nasdaqs-1-decline-leads-averages-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3290223-nasdaqs-1-decline-leads-averages-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290220\" data-ts=\"1502986799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290220-seadrill-moves-to-insulate-seadrill-partners-from-likely-chapter-11-restructure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill moves to insulate Seadrill Partners from likely Chapter 11 restructure</a></h4><ul>     <li>Seadrill (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-5.6%</font>) <a href=\"http://splash247.com/seadrill-step-closer-filing-chapter-11/\" target=\"_blank\">moves closer to declaring Chapter 11</a> bankruptcy, as it <a href=\"http://www.seadrill.com/investor-relations/news/pr-story.aspx?ResultPageURL=http://cws.huginonline.com/S/135817/PR/201708/2127701.xml\" target=\"_blank\">secures amendments</a> to certain credit facilities to insulate its Seadrill Partners (<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='green'>+18%</font>) subsidiary from SDRL's restructuring.</li>     <li>SDRL, weighed by more than $10B in debt, says it completed amendments to three secured credit facilities related to rigs purchased from SDRL by SDLP the company says will insulate SDLP \"from events of default related to the company's likely use of Chapter 11 proceedings to implement its restructuring plan.\"</li>     <li>SDRL says its restructuring plan likely will require substantial impairment or bond conversion; as a result, the company expects shareholders likely will receive \"minimal recovery\" for their existing shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290220\" data-linked=\"Seadrill moves to insulate Seadrill Partners from likely Chapter 11 restructure\" data-tweet=\"$SDRL $SDRL $SDLPF - Seadrill moves to insulate Seadrill Partners from likely Chapter 11 restructure https://seekingalpha.com/news/3290220-seadrill-moves-to-insulate-seadrill-partners-from-likely-chapter-11-restructure?source=tweet\" data-url=\"https://seekingalpha.com/news/3290220-seadrill-moves-to-insulate-seadrill-partners-from-likely-chapter-11-restructure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290215\" data-ts=\"1502985648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290215-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290215\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$WKHS $WPRT $OTIV - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3290215-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3290215-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290214\" data-ts=\"1502985636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSG\" target=\"_blank\">MSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290214-msgminus-2-operating-profits-shrink-broadly\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MSG -2% as operating profits shrink broadly</a></h4><ul>   <li>Madison Square Garden (NASDAQ:<a href='https://seekingalpha.com/symbol/MSG' title='The Madison Square Garden Company'>MSG</a>) is <font color='red'>2% lower</font> today after holding positive ground an hour ago, following <a href=\"https://seekingalpha.com/news/3290097-madison-square-garden-eps-3_58\" target=\"_blank\">fiscal Q4 earnings</a> amid operating losses in its entertainment unit and a decline in operating profit in sports.</li>    <li>Revenues rose 40% to $305.6M, which included $15M in nonrecurring NHL and NBA distributions as well as the impact of including operating results for TAO Group and Boston Calling Events.</li>    <li>Overall, MSG posted an operating loss of $92.5M and adjusted operating loss of $43.6M.</li>    <li>Revenue by segment: MSG Entertainment, $125.9M (up 50%); MSG Sports, $179.6M (up 35%).</li>    <li>Adjusted operating income by segment: MSG Entertainment, -$39.2M (vs. year-ago -$13.2M); MSG Sports, $14.5M (down 21% from year-ago $18.4M).</li>    <li><a href=\"https://seekingalpha.com/pr/16918032-madison-square-garden-company-reports-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3290214\" data-linked=\"MSG -2% as operating profits shrink broadly\" data-tweet=\"$MSG - MSG -2% as operating profits shrink broadly https://seekingalpha.com/news/3290214-msgminus-2-operating-profits-shrink-broadly?source=tweet\" data-url=\"https://seekingalpha.com/news/3290214-msgminus-2-operating-profits-shrink-broadly\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290213\" data-ts=\"1502985605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290213-post-ecb-gains-for-european-stocks-and-euro-are-short-lived\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-ECB gains for European stocks and euro are short-lived</a></h4><ul><li>The euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>) broke lower and European stocks (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) higher after ECB minutes <a href=\"https://seekingalpha.com/news/3290105-european-stocks-move-green-ecb-minutes\" target=\"_blank\">this morning showed</a> rising concern with the strength of the common currency.</li><li>It's hard to fight a currency trend though, and for the euro this year that's been upward and to the right. Though still&nbsp;<font color='red'>down 0.2%&nbsp;</font>on the session, the euro is stronger now than prior to the release of the minutes.</li><li>Stocks have reversed course as well, with the Stoxx 50&nbsp;<font color='red'>down 0.6%</font>, led by Italy's (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWI' title='iShares MSCI Italy Capped ETF'>EWI</a>)&nbsp;<font color='red'>1%</font>&nbsp;and Spain's (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWP' title='iShares MSCI Spain Capped ETF'>EWP</a>)&nbsp;<font color='red'>0.9% decline</font>. Germany (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWG' title='iShares MSCI Germany ETF'>EWG</a>) is&nbsp;<font color='red'>off 0.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290213\" data-linked=\"Post-ECB gains for European stocks and euro are short-lived\" data-tweet=\"$FXE $FEZ $EWI - Post-ECB gains for European stocks and euro are short-lived https://seekingalpha.com/news/3290213-post-ecb-gains-for-european-stocks-and-euro-are-short-lived?source=tweet\" data-url=\"https://seekingalpha.com/news/3290213-post-ecb-gains-for-european-stocks-and-euro-are-short-lived\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290205\" data-ts=\"1502983672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290205-mylan-finalizes-465m-settlement-doj-over-epipen-misclassification-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan finalizes $465M settlement with DOJ over EpiPen misclassification; shares up 2%</a></h4><ul><li>Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+1.7%</font>) <a href=\"https://seekingalpha.com/pr/16918492-mylan-finalizes-settlement-agreement-medicaid-rebate-classification-epipen-auto-injector\" target=\"_blank\">finalizes </a>its settlement with the U.S. Department of Justice related to its misclassification of EpiPen that inflated the price paid by Medicaid. The company agreed to pay $465M to settle the case.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270799-taxpayers-overpaid-1_3b-epipen-800m-mylan-claimed-shares-ease-1-percent\" target=\"_blank\">Taxpayers overpaid $1.3B for EpiPen, $800M more than Mylan claimed; shares ease 1%</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290205\" data-linked=\"Mylan finalizes $465M settlement with DOJ over EpiPen misclassification; shares up 2%\" data-tweet=\"$MYL - Mylan finalizes $465M settlement with DOJ over EpiPen misclassification; shares up 2% https://seekingalpha.com/news/3290205-mylan-finalizes-465m-settlement-doj-over-epipen-misclassification-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3290205-mylan-finalizes-465m-settlement-doj-over-epipen-misclassification-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290204\" data-ts=\"1502983652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290204-target-investments-seen-paying-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target investments seen paying off</a></h4><ul> <li>Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-0.2%</font>) catches a timely upgrade from MKM Partners to a Buy rating on confidence that the retailer's new initiatives will pay off.</li> <li>\"We are cognizant that retail stock valuations are under pressure, but investors are increasingly willing to pay a premium for traditional retailers that are insulated from Amazon or have a viable long term strategy to compete,\" writes analyst Patrick McKeever.</li><li>\"We put Target in the latter group and think this will become increasingly clear over the next several quarters as investments gain traction,\" he observes.</li> <li>MKM's <a href=\"http://www.marketwatch.com/story/targets-stock-gains-after-mkm-analyst-turns-bullish-as-traffic-perks-up-2017-08-17\" target=\"_blank\">price target</a> of $69 reps 22% upside potential for shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290204\" data-linked=\"Target investments seen paying off\" data-tweet=\"$TGT - Target investments seen paying off https://seekingalpha.com/news/3290204-target-investments-seen-paying-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3290204-target-investments-seen-paying-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290196\" data-ts=\"1502982604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADP\" target=\"_blank\">ADP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290196-adpminus-2_9-ackman-lays-out-investment-case-in-webcast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADP -2.9% as Ackman lays out investment case in webcast</a></h4><ul>   <li>Pershing Square's Bill Ackman is making his case against the current situation at Automatic Data Processing (NASDAQ:<a href='https://seekingalpha.com/symbol/ADP' title='Automatic Data Processing, Inc.'>ADP</a>) in this morning's webcast.</li>    <li>Shares in the company are <font color='red'>down 2.9%</font> in response, dropping below $108 for the first time since late July.</li>    <li>Material released ahead of the call argued that it's difficult to compare ADP to competitors when the way it accounts for PEO overstates growth and economic revenue.</li>    <li>Employer Service growth is slowing down as well, and the company's losing market share, Ackman argues.</li>    <li>Ackman said yesterday that ADP <a href=\"https://www.bloomberg.com/news/articles/2017-08-16/ackman-likens-investment-in-adp-to-his-past-success-at-cp-rail\" target=\"_blank\">could have avoided a fight</a> if the board had granted a one-week extension of an Aug. 10 deadline to nominate directors; that was a request that led CEO Carlos Rodriguez to <a href=\"https://seekingalpha.com/news/3288244-adp-ceo-rodriguez-ackman-reminds-spoiled-brat\" target=\"_blank\">characterize Ackman as a \"spoiled brat.\"</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3290196\" data-linked=\"ADP -2.9% as Ackman lays out investment case in webcast\" data-tweet=\"$ADP - ADP -2.9% as Ackman lays out investment case in webcast https://seekingalpha.com/news/3290196-adpminus-2_9-ackman-lays-out-investment-case-in-webcast?source=tweet\" data-url=\"https://seekingalpha.com/news/3290196-adpminus-2_9-ackman-lays-out-investment-case-in-webcast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290166\" data-ts=\"1502982046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290166-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MYOV' title='Myovant Sciences'>MYOV</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma'>NTEC</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a> <font color='red'>-12%</font>. EBIO <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ACHC' title='Acadia Healthcare Co.'>ACHC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290166\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$MYOV $ROKA $NTEC - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3290166-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3290166-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290194\" data-ts=\"1502981974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHU\" target=\"_blank\">CHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290194-china-unicom-pulls-11_7b-mixed-ownership-plan-amid-confusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Unicom pulls $11.7B mixed-ownership plan amid confusion</a></h4><ul>   <li>Chaotic elements are springing up around a <a href=\"https://seekingalpha.com/news/3289834-china-unicom-raise-11_7b-mixed-ownership-push\" target=\"_blank\">mixed-ownership plan for state-owned China Unicom</a> (NYSE:<a href='https://seekingalpha.com/symbol/CHU' title='China Unicom &#40;Hong Kong&#41; Limited'>CHU</a>) that would result in Asia's biggest capital raise since 2010: $11.7B.</li>    <li>Trading in the company's Hong Kong shares was suspended on Wednesday and will stay that way until further notice amid the confusion. Trading in the Shanghai shares have been halted since April. ADRs, meanwhile, are <font color='red'>2.7% lower</font>.</li>    <li>Unicom has now withdrawn the plan temporarily, noting \"technical reasons\" and saying it would file a new plan in three trading days.</li>    <li>The withdrawal came because some terms of the plan <a href=\"https://www.wsj.com/articles/chinas-aim-to-let-state-companies-raise-private-capital-hits-bump-1502973735\" target=\"_blank\">violated recently changed securities rules</a>, <i>The Wall Street Journal</i> reports. In one example, the shares it planned to sell exceeded 40% of outstanding, while new rules have a cap of 20%.</li>    <li>It's not clear whether the company involved Chinese securities regulator CSRC in making the plan.</li>    <li>The investor group was said to include Alibaba (<a href=\"http://seekingalpha.com/symbol/BABA\" target=\"_blank\">BABA</a> <font color='green'>+3.4%</font>), Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color='red'>-2.7%</font>), Didi Chuxing, Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='red'>-1.6%</font>) and JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color='red'>-4.2%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290194\" data-linked=\"China Unicom pulls $11.7B mixed-ownership plan amid confusion\" data-tweet=\"$CHU $CHU $BABA - China Unicom pulls $11.7B mixed-ownership plan amid confusion https://seekingalpha.com/news/3290194-china-unicom-pulls-11_7b-mixed-ownership-plan-amid-confusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3290194-china-unicom-pulls-11_7b-mixed-ownership-plan-amid-confusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290192\" data-ts=\"1502981968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290192-will-disney-pull-trigger-on-day-and-date-releases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Will Disney pull the trigger on day-and-date releases?</a></h4><ul> <li>The Hollywood Reporter's Ben Weiss <a href=\"http://www.hollywoodreporter.com/news/how-disney-can-beat-netflix-stream-movies-day-theyre-theaters-guest-column-1029905\" target=\"_blank\">speculates</a> that Disney's planned launch of a streaming entertainment service increases the odds of a same-day home viewing option of major releases.</li> <li>The day-and-date theatrical release concept is seen by some analysts as an inevitability that could cut into traffic at movie theaters, although the magnitude of the impact is still up for debate.</li> <li>The exhibitor sector has been jumpy over the last few months over streaming concerns and light box office numbers. On a YTD look -- AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='red'>-0.4%</font>), IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='green'>+1.4%</font>), Cinemark Holdings (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color='red'>-0.3%</font>), Marcus (<a href='https://seekingalpha.com/symbol/MCS' title='Marcus Corporation'>MCS</a>), Reading International (<a href='https://seekingalpha.com/symbol/RDI' title='Reading International, Inc.'>RDI</a> <font color='green'>+1.1%</font>), Regal Entertainment (<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a> <font color='red'>-0.6%</font>) are all showing losses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290192\" data-linked=\"Will Disney pull the trigger on day-and-date releases?\" data-tweet=\"$AMC $AMC $IMAX - Will Disney pull the trigger on day-and-date releases? https://seekingalpha.com/news/3290192-will-disney-pull-trigger-on-day-and-date-releases?source=tweet\" data-url=\"https://seekingalpha.com/news/3290192-will-disney-pull-trigger-on-day-and-date-releases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290189\" data-ts=\"1502981879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOV\" target=\"_blank\">MYOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290189-evercore-likes-myovant-sees-three-bagger-shares-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore likes Myovant, sees a three-bagger; shares up 17%</a></h4><ul><li>Thinly traded micro cap Myovant Sciences (<a href='https://seekingalpha.com/symbol/MYOV' title='Myovant Sciences'>MYOV</a> <font color='green'>+17.3%</font>) is up in early trading on increased volume, albeit on turnover of only 63K shares, on the heels of a bullish call from Evercore ISI, who rates the stock a Buy with a $35 (201% upside).</li><li>Two Phase 3 trials, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03049735?intr=relugolix&amp;spons=myovant&amp;phase=2&amp;rank=5\" target=\"_blank\">LIBERTY 1</a> &amp; <a href=\"https://clinicaltrials.gov/ct2/show/NCT03103087?intr=relugolix&amp;spons=myovant&amp;phase=2&amp;rank=4\" target=\"_blank\">LIBERTY 2</a>, are assessing lead product candidate relugolix in women with heavy menstrual bleeding associated with uterine fibroids. The primary completion for both studies is December 2018.</li><li>Another Phase 3, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03085095?intr=relugolix&amp;spons=myovant&amp;phase=2&amp;rank=1\" target=\"_blank\">HERO</a>, is evaluating relugolix in men with advanced prostate cancer. Its primary completion date is September 2019.</li><li>In June, it launched a Phase 3 program to investigate the use of relugolix in women with endometriosis-related pain. Two Phase 3 studies, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03204318?intr=relugolix&amp;spons=myovant&amp;phase=2&amp;rank=3\" target=\"_blank\">SPIRIT 1</a> and <a href=\"https://clinicaltrials.gov/ct2/show/NCT03204331?intr=relugolix&amp;spons=myovant&amp;phase=2&amp;rank=2\" target=\"_blank\">SPIRIT 2</a>, are not yet recruiting patients. The primary completion date for both is December 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3276252-myovant-sciences-initiates-phase-3-clinical-program-relugolix-women-endometriosis-associated\" target=\"_blank\">Myovant sciences initiates Phase 3 clinical program of Relugolix in women with endometriosis-associated pain</a> (June 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290189\" data-linked=\"Evercore likes Myovant, sees a three-bagger; shares up 17%\" data-tweet=\"$MYOV - Evercore likes Myovant, sees a three-bagger; shares up 17% https://seekingalpha.com/news/3290189-evercore-likes-myovant-sees-three-bagger-shares-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3290189-evercore-likes-myovant-sees-three-bagger-shares-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290190\" data-ts=\"1502981824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWDRY\" target=\"_blank\">VWDRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290190-vestasminus-7-q2-earnings-revenue-fall-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vestas -7% as Q2 earnings, revenue fall more than expected</a></h4><ul>     <li>Vestas Wind (<a href='https://seekingalpha.com/symbol/VWDRY' title='Vestas Wind Systems A/S ADR'>OTCPK:VWDRY</a> <font color='red'>-7.6%</font>) tumbles more than 7% after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3290038-vestas-wind-reports-q2-results\" target=\"_blank\">Q2 earnings</a> and warning of <a href=\"http://www.reuters.com/article/us-vestas-wind-results-idUSKCN1AX117\" target=\"_blank\">increasing price pressures</a>.</li>     <li>\"We definitely see a very competitive market... driven by the fact that the market is transforming to market-based auctions and competitive tendering,\" CEO Anders Runevad says.</li>     <li>Vestas says Q2 revenues fell to &euro;2.2B, below the &euro;2.4B forecast, and operating margin fell 20% Q/Q to 12.6%, but order intake totaled 2,667 MW, better than expectations for 2,501 MW.</li>     <li>For the full year, Vestas maintains guidance for revenue of &euro;9.25B-&euro;10.25B, EBIT margin before special items of 12%-14%, total investments of ~&euro;350M and free cash flow of a minimum &euro;700M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290190\" data-linked=\"Vestas -7% as Q2 earnings, revenue fall more than expected\" data-tweet=\"$VWDRY - Vestas -7% as Q2 earnings, revenue fall more than expected https://seekingalpha.com/news/3290190-vestasminus-7-q2-earnings-revenue-fall-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3290190-vestasminus-7-q2-earnings-revenue-fall-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290184\" data-ts=\"1502980437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMED\" target=\"_blank\">GMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290184-fda-oks-globus-medicals-excelsius-gps-system-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OK&#39;s Globus Medical&#39;s Excelsius GPS system; shares up 6%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/16918364-globus-medical-announces-fda-510-k-clearance-excelsius-gps\" target=\"_blank\">grants </a>510(k) clearance for Globus Medical's (<a href='https://seekingalpha.com/symbol/GMED' title='Globus Medical'>GMED</a> <font color='green'>+6.4%</font>) robotic guidance and navigation system, Excelsius GPS.</li><li>The company says its platform technology supports minimally invasive and open orthopedic and neurosurgical procedures, with screw placement applications in spine and orthopedic surgery. It is designed to minimize radiation exposure, streamline workflow and reproducibly assist in implant placement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290184\" data-linked=\"FDA OK&#39;s Globus Medical&#39;s Excelsius GPS system; shares up 6%\" data-tweet=\"$GMED - FDA OK&#39;s Globus Medical&#39;s Excelsius GPS system; shares up 6% https://seekingalpha.com/news/3290184-fda-oks-globus-medicals-excelsius-gps-system-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3290184-fda-oks-globus-medicals-excelsius-gps-system-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290183\" data-ts=\"1502980214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290183-natural-gas-inventory-builds-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds more than expected</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a>&nbsp;<strong>+53 Bcf</strong> vs. +47 Bcf consensus, +28 Bcf last week.</li>     <li>Futures&nbsp;<font color='red'>-0.31%</font>&nbsp;to $2.881.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290183\" data-linked=\"Natural gas inventory builds more than expected\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds more than expected https://seekingalpha.com/news/3290183-natural-gas-inventory-builds-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3290183-natural-gas-inventory-builds-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290182\" data-ts=\"1502980081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBC\" target=\"_blank\">WBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290182-wabco-holdings-still-buy-baml\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wabco Holdings still a Buy at BAML</a></h4><ul>     <li>A CFO departure at Wabco Holdings (<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a> <font color='red'>-0.6%</font>) isn't pushing Bank of America Merrill Lynch off a <a href=\"https://www.streetinsider.com/Analyst+EPS+Change/Wabco+Holdings+%28WBC%29%3A+CFO+Departure+Spurs+M%26A+Speculation+-+BofA/13215767.html\" target=\"_blank\">Buy rating</a>.</li>     <li>BAML keeps a $150 price target on Wabco as it notes M&amp;A potential is still in the mix.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3289818-wabco-holdings-cfo-mahendra-rajah-resigns\" target=\"_blank\">WABCO Holdings CFO Mahendra-Rajah resigns</a> (Aug. 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290182\" data-linked=\"Wabco Holdings still a Buy at BAML\" data-tweet=\"$WBC - Wabco Holdings still a Buy at BAML https://seekingalpha.com/news/3290182-wabco-holdings-still-buy-baml?source=tweet\" data-url=\"https://seekingalpha.com/news/3290182-wabco-holdings-still-buy-baml\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290180\" data-ts=\"1502979675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGN\" target=\"_blank\">EGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290180-wsj-elliot-joins-corvex-in-pushing-for-energen-to-explore-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Elliot joins Corvex in pushing for Energen to explore sale</a></h4><ul>     <li>Elliott Management <a href=\"https://www.wsj.com/articles/elliott-management-wants-energen-to-explore-sale-options-1502978202\" target=\"_blank\">owns a 4%-5% stake</a> in Energen (<a href='https://seekingalpha.com/symbol/EGN' title='Energen Corporation'>EGN</a> <font color='green'>+2.4%</font>) and is joining with Corvex Management in urging a sale, <em>WSJ</em> reports.</li>     <li>Corvex raised its own position in EGN to ~10% <a href=\"https://seekingalpha.com/news/3289273-corvex-ups-active-stake-energen-10_1-percent-warns-proxy-fight\" target=\"_blank\">earlier this week</a>, which gives it a pathway under Alabama law to call a special meeting and add as many as six directors to the nine who already sit on the E&amp;P company&rsquo;s board.</li>     <li>The two activist hedge funds believe EGN's Permian Basin properties would attract draw oil and gas producers looking to expand in the area as well as companies seeking to enter the prolific play; EGN said <a href=\"https://seekingalpha.com/news/3274594-energen-boosts-production-view-ends-strategic-review\" target=\"_blank\">in June</a> that it had completed a strategic review and was not interested in selling.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290180\" data-linked=\"WSJ: Elliot joins Corvex in pushing for Energen to explore sale\" data-tweet=\"$EGN - WSJ: Elliot joins Corvex in pushing for Energen to explore sale https://seekingalpha.com/news/3290180-wsj-elliot-joins-corvex-in-pushing-for-energen-to-explore-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3290180-wsj-elliot-joins-corvex-in-pushing-for-energen-to-explore-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290179\" data-ts=\"1502979569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSEC\" target=\"_blank\">PSEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290179-prospect-capitalminus-2_5-sa-contributor-mulls-size-of-dividend-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prospect Capital -2.5% as SA contributor mulls size of dividend cut</a></h4><ul><li>The price action in Prospect Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/PSEC' title='Prospect Capital Corporation'>PSEC</a>) over the past few weeks has been pretty nasty ahead of what many expect will be the announcement of a dividend cut, <a href=\"https://seekingalpha.com/article/4099687-prospect-capital-dividend-cut-20-percent-30-percent\" target=\"_blank\">writes BDC Buzz</a>.</li><li>The question at hand: What might be the size of the cut, and are the shares appropriately priced for that?</li><li>While management has shown a past willingness to under-earn the dividend for sizable periods, says Buzz, he estimates the new monthly payout to be $0.06-$0.065 per share - a roughly 20%-30% reduction - should the dividend be aligned with expected earnings.</li><li>Shares are an outlier to the downside in the BDC sector today,&nbsp;<font color='red'>off 2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290179\" data-linked=\"Prospect Capital -2.5% as SA contributor mulls size of dividend cut\" data-tweet=\"$PSEC - Prospect Capital -2.5% as SA contributor mulls size of dividend cut https://seekingalpha.com/news/3290179-prospect-capitalminus-2_5-sa-contributor-mulls-size-of-dividend-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3290179-prospect-capitalminus-2_5-sa-contributor-mulls-size-of-dividend-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290173\" data-ts=\"1502978515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290173-valeant-up-4-on-resolution-of-manufacturing-issues-tampa-site\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant up 4% on resolution of manufacturing issues at Tampa site</a></h4><ul><li>Valeant Pharmaceuticals (VRX <font color='green'>+3.7%</font>) is up in early trading on the heels of its announcement that it has resolved the manufacturing issues at its B + L site in Tampa, FL.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289988-fda-ok-valeants-b-l-site-florida-overhang-removed-regulatory-submissions-shares-ahead-1\" target=\"_blank\">FDA OK with Valeant's B + L site in Florida, overhang removed from regulatory submissions; shares ahead 1% after hours</a> (Aug. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290173\" data-linked=\"Valeant up 4% on resolution of manufacturing issues at Tampa site\" data-tweet=\"$BHC - Valeant up 4% on resolution of manufacturing issues at Tampa site https://seekingalpha.com/news/3290173-valeant-up-4-on-resolution-of-manufacturing-issues-tampa-site?source=tweet\" data-url=\"https://seekingalpha.com/news/3290173-valeant-up-4-on-resolution-of-manufacturing-issues-tampa-site\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>132&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290169\" data-ts=\"1502978266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290169-opko-health-teams-up-u-s-veterans-focused-health-group-on-va-bid-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opko Health teams up with U.S. veterans-focused health group on VA bid; shares up 1%</a></h4><ul><li>Opko Health (<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color='green'>+0.8%</font>) has signed a <a href=\"https://www.sec.gov/Archives/edgar/data/944809/000129993317000842/htm_55265.htm\" target=\"_blank\">Commitment Letter</a> with Veterans Accountable Care Group, LLC &#40;VACG&#41;&nbsp;in connection with a bid by its affiliate Veterans Accountable Care Organization &#40;VACO&#41; for a Veterans Health Administration &#40;VHA&#41; contract related to the Community Care Network, a project aimed at connecting veterans who lack easy access to VA facilities to local healthcare providers.</li><li>If the bid is successful, Opko will acquire a 15% stake in VACO and will provide (or arrange with a third-party lender) a $50M line of credit for VACG in order for VACO to satisfy the financial stability requirement of the contract.</li><li>Opko's BioReference Laboratories will provide lab services for CCN, a region in the eastern U.S. (MA, NH, VT, NY, PA, NJ, RI, CT, MD, VA, WV and NC) that includes ~2.1M veterans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290169\" data-linked=\"Opko Health teams up with U.S. veterans-focused health group on VA bid; shares up 1%\" data-tweet=\"$OPK - Opko Health teams up with U.S. veterans-focused health group on VA bid; shares up 1% https://seekingalpha.com/news/3290169-opko-health-teams-up-u-s-veterans-focused-health-group-on-va-bid-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3290169-opko-health-teams-up-u-s-veterans-focused-health-group-on-va-bid-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290165\" data-ts=\"1502977583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290165-commscopeplus-2_3-morgan-stanley-upgrades-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope +2.3% as Morgan Stanley upgrades to Overweight</a></h4><ul>   <li>CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company Inc.'>COMM</a>) is <font color='green'>up 2.3%</font> premarket after a boost to Overweight at Morgan Stanley, which sees an attractive entry point of late.</li>    <li>Shares have <font color='red'>declined nearly 15%</font> in 2017.</li>    <li>The company's \"positioned to be a wallet share gainer\" as more efficient networks get built, says analyst Meta Marshall.</li>    <li>Actions from the new administration that are service-provider friendly don't hurt, Marshall notes, though the firm remains cautious around capex growth for telecoms.</li>    <li>MS has a price target of $38, implying 13% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290165\" data-linked=\"CommScope +2.3% as Morgan Stanley upgrades to Overweight\" data-tweet=\"$COMM - CommScope +2.3% as Morgan Stanley upgrades to Overweight https://seekingalpha.com/news/3290165-commscopeplus-2_3-morgan-stanley-upgrades-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3290165-commscopeplus-2_3-morgan-stanley-upgrades-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290164\" data-ts=\"1502977369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290164-brazil-regulator-orders-eletrobras-to-return-951m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil regulator orders Eletrobras to return $951M</a></h4><ul>     <li>Brazil's electricity regulator orders Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='red'>-4.9%</font>) to <a href=\"http://www.reuters.com/article/us-eletrobras-regulator-idUSKCN1AX005\" target=\"_blank\">return 3B reais</a> ($951M) received as subsidies to a government fund within 90 days.</li>     <li>The payments were made during 2009-16 to EBR subsidiary Amazonas Distribuidora de Energia, but the regulator says it recalculated the subsidies and found Amazonas received substantially more than it should have.</li>     <li>The subsidy rules are set by CCC, a government fund that subsidizes power companies not included in the grid to pay for more expensive thermal generation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290164\" data-linked=\"Brazil regulator orders Eletrobras to return $951M\" data-tweet=\"$EBR - Brazil regulator orders Eletrobras to return $951M https://seekingalpha.com/news/3290164-brazil-regulator-orders-eletrobras-to-return-951m?source=tweet\" data-url=\"https://seekingalpha.com/news/3290164-brazil-regulator-orders-eletrobras-to-return-951m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290163\" data-ts=\"1502977332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290163-alibaba-beats-q1-estimates-nearly-doubles-profits-shares-up-3_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba beats Q1 estimates, nearly doubles profits; shares up 3.7%</a></h4><ul><li>        Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) announces Q1 results with EPS and revenue beats and nearly doubled profits.</li><li>               Profits were up 94% to $2.2B driven by sales strengths particularly in the core commerce business, which was up 58% on the year to $6.3B.&nbsp;</li><li>               Other segment revenue: cloud computing, $359M (+96%); digital media and entertainment, $602M (+30%); innovation initiatives and others, $95M (+21%).&nbsp;</li><li>               Alibaba ended the quarter with $21.85B in cash and equivalents. The company&rsquo;s net cash from operating activities was $3.7B, up 69%. FCF was $3.3B. &nbsp;&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16917971-alibaba-group-announces-june-quarter-2017-results\" target=\"_blank\">Press release</a>&nbsp;</li><li>               Alibaba shares are&nbsp;<font color='green'>up 3.66%</font>&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290079-alibaba-beats-0_24-beats-revenue\" target=\"_blank\">Alibaba beats by $0.24, beats on revenue</a> (Aug. 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290163\" data-linked=\"Alibaba beats Q1 estimates, nearly doubles profits; shares up 3.7%\" data-tweet=\"$BABA - Alibaba beats Q1 estimates, nearly doubles profits; shares up 3.7% https://seekingalpha.com/news/3290163-alibaba-beats-q1-estimates-nearly-doubles-profits-shares-up-3_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3290163-alibaba-beats-q1-estimates-nearly-doubles-profits-shares-up-3_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290157\" data-ts=\"1502976753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKA\" target=\"_blank\">ROKA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290157-roka-bio-proceeds-liquidation-agrees-to-sell-all-assets-for-17_5m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roka Bio proceeds with liquidation, agrees to sell all assets for $17.5M</a></h4><ul><li>Roka Bioscience (<a href='https://seekingalpha.com/symbol/ROKA' title='Roka Bioscience'>ROKA</a>) inks an <a href=\"https://seekingalpha.com/pr/16918176-roka-bioscience-inc-agrees-sell-assets-subsidiary-institute-environmental-health-inc\" target=\"_blank\">agreement </a>with Institute for Environmental Health for the sale of substantially all of its assets for $17.5M in cash. IEH will operate the business under a wholly-owned subsidiary called Rokabio.</li><li>Roka will provide transition services to IEH through the end of the year.</li><li>CEO Mary Duseau says, \"The announcement of this asset sale follows an extensive review of a range of strategic alternatives for Roka Bioscience, including obtaining further financing to continue as an independent entity and exploring the possibility of mergers and acquisitions. This transaction represents the conclusion of a thorough process. &nbsp;We believe that the asset sale and anticipated liquidation will provide the greatest value to our stockholders.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3290157\" data-linked=\"Roka Bio proceeds with liquidation, agrees to sell all assets for $17.5M\" data-tweet=\"$ROKA - Roka Bio proceeds with liquidation, agrees to sell all assets for $17.5M https://seekingalpha.com/news/3290157-roka-bio-proceeds-liquidation-agrees-to-sell-all-assets-for-17_5m?source=tweet\" data-url=\"https://seekingalpha.com/news/3290157-roka-bio-proceeds-liquidation-agrees-to-sell-all-assets-for-17_5m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290156\" data-ts=\"1502976288\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFI\" target=\"_blank\">GFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290156-gold-fieldsplus-4-despite-25-drop-in-h1-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold Fields +4% despite 25% drop in H1 profit</a></h4><ul>     <li>Gold Fields (NYSE:<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>)&nbsp;<font color='green'>+4%</font> premarket despite reporting much lower <a href=\"https://seekingalpha.com/news/3290037-gold-fields-reports-1h-results\" target=\"_blank\">H1 earnings</a> compared to a year ago, as the South African miner <a href=\"http://www.nasdaq.com/article/gold-fields-h1-earnings-fall-on-stronger-local-currencies-20170817-00110\" target=\"_blank\">maintains its full-year production targets</a>.</li>     <li>GFI says normalized H1 earnings fell 25% Y/Y to $77M from $103M, while normalized earnings from continuing operations were $80M, 18% lower than the $98M a year ago, but GFI still expects gold production for the full year to reach 2.1M-2.15M oz.</li>     <li>H1 revenue rose 2.3% Y/Y to $1.33B, gold production edged 0.3% higher to 1.05M oz., and the price received per gold oz. gain 1.2% to $1,232; output at the South Deep mine fell 15% Y/Y due to fatalities and multiple falls of ground.</li>     <li>GFI also says it will pay an H1 dividend of 40 rand cents/share, down from 50 rand cents/share a year earlier.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290156\" data-linked=\"Gold Fields +4% despite 25% drop in H1 profit\" data-tweet=\"$GFI - Gold Fields +4% despite 25% drop in H1 profit https://seekingalpha.com/news/3290156-gold-fieldsplus-4-despite-25-drop-in-h1-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3290156-gold-fieldsplus-4-despite-25-drop-in-h1-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290154\" data-ts=\"1502975908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRIO\" target=\"_blank\">DRIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290154-dariohealth-executes-4_3m-private-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarioHealth executes $4.3M private capital raise</a></h4><ul><li>DarioHeath (NASDAQ:<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a>) inks <a href=\"https://seekingalpha.com/pr/16918196-dariohealth-raises-4_28-million-private-placement-offerings\" target=\"_blank\">agreements </a>with domestic and ex-U.S. investors for the sale of common stock and Series B Convertible Preferred Stock yielding gross proceeds of ~$4.3M. Closing date is August 22.</li><li>The company will issue 483,333 shares of common stock at $1.80 and 1,894,446 Series B shares at $1.80, convertible into common shares at a 1:1 ratio and paying a 6% dividend upon conversion.</li><li>Yesterday's close was $1.84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290154\" data-linked=\"DarioHealth executes $4.3M private capital raise\" data-tweet=\"$DRIO - DarioHealth executes $4.3M private capital raise https://seekingalpha.com/news/3290154-dariohealth-executes-4_3m-private-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3290154-dariohealth-executes-4_3m-private-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290151\" data-ts=\"1502975508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290151-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3290137-lakeland-prices-stock-offering-13_80-shares-13-percent-premarket\" target=\"_blank\">pricing</a> public offering of 725K common shares.</li><li><a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3289962-vipshop-holdings-misses-0_02-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3289979-l-brands-beats-0_04-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3290151\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$LAKE $VIPS $IDXG - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3290151-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3290151-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290149\" data-ts=\"1502975384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290149-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a> <font color='green'>+23%</font>.</li><li><a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='green'>+19%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3290056-stage-stores-misses-0_11-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color='green'>+5%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3290079-alibaba-beats-0_24-beats-revenue\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290149\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SDLPF $SSI $BABA - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3290149-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3290149-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290145\" data-ts=\"1502974896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTPH\" target=\"_blank\">TTPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290145-tetraphase-pharmas-european-marketing-application-for-iv-eravacycline-accepted-ema-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetraphase Pharma&#39;s European marketing application for IV eravacycline accepted by EMA; shares ahead 5% premarket</a></h4><ul><li>Tetraphase Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals'>TTPH</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16918184-tetraphase-pharmaceuticals-announces-submission-validation-iv-eravacycline-marketing\" target=\"_blank\">announcement </a>that the European Medicines Agency &#40;EMA&#41; has validated its marketing application seeking approval for IV eravacycline for the treatment of complicated intra-abdominal infections.</li><li>It plans to file its marketing application in the U.S. in Q1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290145\" data-linked=\"Tetraphase Pharma&#39;s European marketing application for IV eravacycline accepted by EMA; shares ahead 5% premarket\" data-tweet=\"$TTPH - Tetraphase Pharma&#39;s European marketing application for IV eravacycline accepted by EMA; shares ahead 5% premarket https://seekingalpha.com/news/3290145-tetraphase-pharmas-european-marketing-application-for-iv-eravacycline-accepted-ema-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3290145-tetraphase-pharmas-european-marketing-application-for-iv-eravacycline-accepted-ema-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290138\" data-ts=\"1502974375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290138-grocery-stores-on-watch-after-wal-mart-posts-strong-food-comp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery stores on watch after Wal-Mart posts strong food comp</a></h4><ul> <li>Grocery store stocks could feel some pressure today after Wal-Mart reported its strongest quarterly comparable sales growth mark across food categories in five years. The Bentonville giant, which is continuing to sacrifice margins for grocery market share, lowered its annual profit guidance earlier today.</li> <li>Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a>) is already <font color='red'>down 1.19%</font> in premarket trading. Wal-Mart's grocery pricing could also be a factor for Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>), Smart &amp; Final Stores (NYSE:<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a>), Ingles Markets (NASDAQ:<a href='https://seekingalpha.com/symbol/IMKTA' title='Ingles Markets, Incorporated'>IMKTA</a>), Sprouts Farmers Market (NASDAQ:<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a>), Weis Markets (NYSE:<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a>) and even Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3290091-weak-profit-guidance-clips-wal-mart\" target=\"_blank\">Weak profit guidance clips Wal-Mart</a> (Aug. 17)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290138\" data-linked=\"Grocery stores on watch after Wal-Mart posts strong food comp\" data-tweet=\"$KR $KR $SVU - Grocery stores on watch after Wal-Mart posts strong food comp https://seekingalpha.com/news/3290138-grocery-stores-on-watch-after-wal-mart-posts-strong-food-comp?source=tweet\" data-url=\"https://seekingalpha.com/news/3290138-grocery-stores-on-watch-after-wal-mart-posts-strong-food-comp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290137\" data-ts=\"1502974336\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAKE\" target=\"_blank\">LAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290137-lakeland-prices-stock-offering-13_80-shares-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lakeland prices stock offering at $13.80; shares down 13% premarket</a></h4><ul><li>Thinly traded micro cap Lakeland Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LAKE' title='Lakeland Industries, Inc.'>LAKE</a>) slumps&nbsp;<font color='red'>13%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16918154-lakeland-industries-prices-10-million-underwritten-offering\" target=\"_blank\">public offering</a> of 725K shares of common stock at $13.80 per share yielding gross proceeds of $10M. Closing date is August 22.</li><li>Yesterday's close was $15.65.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289977-lakeland-preliminary-fiscal-q2-revenues-8-percent-eps-high-0_21-shares-6-percent-hours\" target=\"_blank\">Lakeland preliminary fiscal Q2 revenues up ~8%; EPS as high as $0.21; shares down 6% after hours on planned equity offering</a> (Aug. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290137\" data-linked=\"Lakeland prices stock offering at $13.80; shares down 13% premarket\" data-tweet=\"$LAKE - Lakeland prices stock offering at $13.80; shares down 13% premarket https://seekingalpha.com/news/3290137-lakeland-prices-stock-offering-13_80-shares-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3290137-lakeland-prices-stock-offering-13_80-shares-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290134\" data-ts=\"1502973708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290134-ut-southwestern-med-center-to-conduct-study-to-assess-clinical-utility-of-biocepts-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UT Southwestern Med Center to conduct study to assess clinical utility of Biocept&#39;s Target Selector platform in ALK+ lung cancer patients; shares ahead 5% premarket</a></h4><ul><li>Thinly traded nano cap Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on higher-than-normal volume in response to its <a href=\"https://seekingalpha.com/pr/16918140-biocept-ut-southwestern-medical-center-announce-clinical-study-profile-monitor-non-small-cell\" target=\"_blank\">announcement </a>of an agreement with the University of Texas Southwestern Medical Center to conduct a study assessing the clinical utility of its <a href=\"https://biocept.com/technology/lung-cancer-offering/\" target=\"_blank\">Target Selector</a> platform for patients with ALK-positive non-small cell lung cancer &#40;NSCLC&#41; who are being treated with an ALK inhibitor.</li><li>A second arm of the study will evaluate patients with rare cancers (e.g., anaplastic thyroid cancer) to see if driver mutations such as ALK rearrangements can be identified and treated with targeted therapy to improve patient outcomes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290134\" data-linked=\"UT Southwestern Med Center to conduct study to assess clinical utility of Biocept&#39;s Target Selector platform in ALK+ lung cancer patients; shares ahead 5% premarket\" data-tweet=\"$BIOC - UT Southwestern Med Center to conduct study to assess clinical utility of Biocept&#39;s Target Selector platform in ALK+ lung cancer patients; shares ahead 5% premarket https://seekingalpha.com/news/3290134-ut-southwestern-med-center-to-conduct-study-to-assess-clinical-utility-of-biocepts-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3290134-ut-southwestern-med-center-to-conduct-study-to-assess-clinical-utility-of-biocepts-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290123\" data-ts=\"1502972907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290123-endologix-afx-afx2-endografts-edge-out-rivals-in-head-to-head-study-shares-ahead-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix AFX/AFX2 endografts edge out rivals in head-to-head study; shares ahead 1% premarket</a></h4><ul><li>Endologix (NASDAQ:<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>) is up&nbsp;<font color='green'>1%&nbsp;</font>premarket, albeit on only 700 shares, in response to its <a href=\"https://seekingalpha.com/pr/16918061-endologix-announces-positive-clinical-results-leopard-clinical-study\" target=\"_blank\">announcement </a>of positive preliminary results from <a href=\"https://clinicaltrials.gov/ct2/show/NCT02407457?titles=leopard&amp;spons=endologix&amp;rank=1\" target=\"_blank\">LEOPARD</a>, a 458-subject comparative study between its AFX and AFX2 endografts and other commercially available bifurcated aortic endografts.</li><li>At one-year of follow-up, the freedom from Aneurysm-related complications &#40;ARC&#41; was 84.7% with AFX/AFX2 versus 82.0% with the other devices.</li><li>Based upon the number of additional subjects to prove superiority, the company plans to halt further randomization in LEOPARD and will continue to follow current participants for five years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290123\" data-linked=\"Endologix AFX/AFX2 endografts edge out rivals in head-to-head study; shares ahead 1% premarket\" data-tweet=\"$ELGX - Endologix AFX/AFX2 endografts edge out rivals in head-to-head study; shares ahead 1% premarket https://seekingalpha.com/news/3290123-endologix-afx-afx2-endografts-edge-out-rivals-in-head-to-head-study-shares-ahead-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3290123-endologix-afx-afx2-endografts-edge-out-rivals-in-head-to-head-study-shares-ahead-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290122\" data-ts=\"1502972802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290122-sibanye-gold-to-set-aside-1_1b-rand-for-possible-lung-disease-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye Gold to set aside 1.1B rand for possible lung disease settlement</a></h4><ul>     <li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a>) <font color='red'>-2%</font> premarket after saying it will <a href=\"https://af.reuters.com/article/africaTech/idAFKCN1AX0R4-OZABS\" target=\"_blank\">set aside 1.1B rand</a> (~$84M) for a possible settlement with miners who contracted lung diseases at work.</li>     <li>A class action suit, mostly relating to the fatal lung disease silicosis, was filed on behalf of miners in 2012; Gold Fields, Anglo American and Harmony Gold already have set aside ~$200M combined toward a possible settlement.</li>     <li>Because of the impairment, as well as an average 14% appreciation of the South African rand vs. the U.S. dollar, SBGL expects to <a href=\"https://www.iol.co.za/business-report/companies/sibanye-lost-r48-billion-in-six-months-10830060\" target=\"_blank\">report an H1 loss of at least US$0.24/share</a>, with a headline loss of at least US$0.11.</li>     <li>SBGL says H1 gold production fell 8% Y/Y to 688K oz. while operating costs rose 3% to 8.9B rand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290122\" data-linked=\"Sibanye Gold to set aside 1.1B rand for possible lung disease settlement\" data-tweet=\"$SBGL - Sibanye Gold to set aside 1.1B rand for possible lung disease settlement https://seekingalpha.com/news/3290122-sibanye-gold-to-set-aside-1_1b-rand-for-possible-lung-disease-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3290122-sibanye-gold-to-set-aside-1_1b-rand-for-possible-lung-disease-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290111\" data-ts=\"1502971344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AERI\" target=\"_blank\">AERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290111-valeants-success-fixing-tampa-manufacturing-issues-plus-for-aerie-pharma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant&#39;s success at fixing Tampa manufacturing issues a plus for Aerie Pharma</a></h4><ul><li>Aerie Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) was up&nbsp;<font color='green'>4%</font>&nbsp;after hours yesterday (no premarket trades have been reported yet) on the news that Valeant Pharmaceuticals has finally fixed the manufacturing problems at its Bausch + Lomb site in Tampa, FL.</li><li>The <a href=\"https://endpts.com/aerie-boosted-as-valeants-troubled-tampa-facility-looks-like-its-coming-out-of-rehab/\" target=\"_blank\">development is a positive</a> for Aerie because Rhopressa (netarsudil ophthalmic solution) is manufactured there. Valeant's success is timely. Aerie's U.S. marketing application is currently under FDA review with an action date of February 28, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3267157-fda-sets-action-date-february-28-2018-rhopressa-nda\" target=\"_blank\">FDA sets action date of February 28, 2018 for Rhopressa NDA</a> (May 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289988-fda-ok-valeants-b-l-site-florida-overhang-removed-regulatory-submissions-shares-ahead-1\" target=\"_blank\">FDA OK with Valeant's B + L site in Florida, overhang removed from regulatory submissions; shares ahead 1% after hours</a> (Aug. 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3290111\" data-linked=\"Valeant&#39;s success at fixing Tampa manufacturing issues a plus for Aerie Pharma\" data-tweet=\"$AERI - Valeant&#39;s success at fixing Tampa manufacturing issues a plus for Aerie Pharma https://seekingalpha.com/news/3290111-valeants-success-fixing-tampa-manufacturing-issues-plus-for-aerie-pharma?source=tweet\" data-url=\"https://seekingalpha.com/news/3290111-valeants-success-fixing-tampa-manufacturing-issues-plus-for-aerie-pharma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290099\" data-ts=\"1502970447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290099-ecb-jawbones-euro-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ECB jawbones euro lower</a></h4><ul><li>\"Concerns were expressed about the risk of the exchange-rate overshooting in the future,\" according to the<a href=\"https://www.ecb.europa.eu/press/accounts/2017/html/ecb.mg170817.en.html\" target=\"_blank\"> just-released minutes of</a> the ECB's July 19-20 meeting.</li><li>Already lower on the session, the euro (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>) has slipped further vs. the dollar, now&nbsp;<font color='red'>down 0.75%</font>&nbsp;to $1.1676. That's still within a couple of cents of its highest level since early 2015.</li><li>The common currency is&nbsp;<font color='red'>down 0.5%</font>&nbsp;vs. the pound (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>), but also still near a multiyear high.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a>, <a href='https://seekingalpha.com/symbol/EUO' title='ProShares UltraShort Euro ETF'>EUO</a>, <a href='https://seekingalpha.com/symbol/FXB' title='CurrencyShares British Pound Sterling Trust ETF'>FXB</a>, <a href='https://seekingalpha.com/symbol/ERO' title='iPath EUR/USD Exchange Rate ETN'>ERO</a>, <a href='https://seekingalpha.com/symbol/GBB' title='iPath GBP/USD Exchange Rate ETN'>GBB</a>, <a href='https://seekingalpha.com/symbol/DRR' title='Market Vectors Double Short Euro ETN'>DRR</a>, <a href='https://seekingalpha.com/symbol/ULE' title='ProShares Ultra Euro ETF'>ULE</a>, <a href='https://seekingalpha.com/symbol/EUFX' title='ProShares Short Euro ETF'>EUFX</a>, <a href='https://seekingalpha.com/symbol/URR' title='Market Vectors Double Long Euro ETN'>URR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3290099\" data-linked=\"ECB jawbones euro lower\" data-tweet=\"$FXE $FXB $EUO - ECB jawbones euro lower https://seekingalpha.com/news/3290099-ecb-jawbones-euro-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3290099-ecb-jawbones-euro-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290096\" data-ts=\"1502969826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290096-redhill-nabs-u-s-rights-to-gerd-med-esomeprazole-strontium-dr-capsules-shares-up-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill nabs U.S. rights to GERD med Esomeprazole Strontium DR Capsules; shares up 4% premarket</a></h4><ul><li>RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) inks a <a href=\"https://seekingalpha.com/pr/16918000-redhill-biopharma-announces-u-s-commercialization-agreement-fda-approved-gi-product\" target=\"_blank\">commercialization agreement</a> with ParaPRO LLC securing the exclusive rights to promote Esomeprazole Strontium Delayed-Release &#40;DR&#41; Capsules to gastroenterologists in certain U.S. territories for a initial term of three years. The product is FDA-approved to treat gastroesophageal reflux disease &#40;GERD&#41; and other GI conditions.</li><li>Under the terms of the agreement, RedHill will not obligated for any upfront or milestone payments, but will share revenues with ParaPRO per an agreed-upon split.</li><li>U.S. launch will commence in the coming weeks.</li><li>Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket but only on 900 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290096\" data-linked=\"RedHill nabs U.S. rights to GERD med Esomeprazole Strontium DR Capsules; shares up 4% premarket\" data-tweet=\"$RDHL - RedHill nabs U.S. rights to GERD med Esomeprazole Strontium DR Capsules; shares up 4% premarket https://seekingalpha.com/news/3290096-redhill-nabs-u-s-rights-to-gerd-med-esomeprazole-strontium-dr-capsules-shares-up-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3290096-redhill-nabs-u-s-rights-to-gerd-med-esomeprazole-strontium-dr-capsules-shares-up-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290094\" data-ts=\"1502969203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSY\" target=\"_blank\">HSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290094-bernstein-sees-upside-for-hershey\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein sees upside for Hershey</a></h4><ul> <li>Shares of Hershey (NYSE:<a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a>) are on watch after Bernstein lifts the food stock to an Outperform rating from Market Perform.</li> <li>The investment firm lifts its price target to $127 from $109 to rep 20% upside potential.</li> <li>HSY <font color='green'>+0.63%</font> premarket to $106.71.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290094\" data-linked=\"Bernstein sees upside for Hershey\" data-tweet=\"$HSY - Bernstein sees upside for Hershey https://seekingalpha.com/news/3290094-bernstein-sees-upside-for-hershey?source=tweet\" data-url=\"https://seekingalpha.com/news/3290094-bernstein-sees-upside-for-hershey\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290091\" data-ts=\"1502968930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290091-weak-profit-guidance-clips-wal-mart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak profit guidance clips Wal-Mart</a></h4><ul> <li>Wal-Mart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) reports comparable sales increased 1.7% in Q2 to match the estimates of analysts.</li> <li>Comparable sales rose 1.8% in the U.S. on a 1.3% gain in U.S. traffic and 0.5% rise in average ticket.</li> <li>Sam's Club comparable sales were up 1.2% vs. 1.4% consensus.</li> <li>Walmart International sales fell 1.0% to $28.3B.</li> <li>E-commerce sales were up 60% during the quarter as new acquisitions contributed to the growth.</li> <li>The company sees Q3 EPS of $0.90 to $0.98 vs. $0.98 consensus and full-year EPS of $4.30 to $4.40 vs. $4.36 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290087-wal-mart-beats-0_01-beats-revenue\" target=\"_blank\">Wal-Mart beats by $0.01, beats on revenue</a> (Aug. 17)</li> <li>Shares of Wal-Mart are <font color='red'>down 1.89%</font> in premarket action to $79.45.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3290091\" data-linked=\"Weak profit guidance clips Wal-Mart\" data-tweet=\"$WMT - Weak profit guidance clips Wal-Mart https://seekingalpha.com/news/3290091-weak-profit-guidance-clips-wal-mart?source=tweet\" data-url=\"https://seekingalpha.com/news/3290091-weak-profit-guidance-clips-wal-mart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290081\" data-ts=\"1502967350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BONT\" target=\"_blank\">BONT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290081-on-bon-ton-stores-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Bon-Ton Stores&#39; Q2</a></h4><ul><li>The Bon-Ton Stores (NASDAQ:<a href=\"http://seekingalpha.com/symbol/BONT\" target=\"_blank\">BONT</a>) reports comparable-store sales squeezed 6.1% in&nbsp;<a href=\"https://seekingalpha.com/pr/16917964-bon-ton-stores-inc-reports-second-quarter-fiscal-2017-results\" target=\"_blank\">Q2</a>.</li><li>Proprietary credit card sales rate rose 40 bps to 57.4%.</li><li>Gross margin rate fell 100 bps to 35.5%.</li><li>SG&amp;A expense rate improved 120 bps to 37.9%.</li><li>Merchandise inventories -5.1% to $658.22M.</li><li>Store count -7 Y/Y to 260.</li><li>The company ended the quarter with excess borrowing capacity of $171M&nbsp;under its revolving credit facility.</li><li><strong>FY2017 Guidance</strong>: Comparable sales: -3.5% to -4.5%; Gross margin rate: -40 bps to -60 bps; SG&amp;A: $834M to $839M; Adjusted EBITDA: $115M to $125M; Diluted EPS: -$2.08 to -$2.59; Shares outstanding: $20.3M; Capex: not to exceed $30M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3290081\" data-linked=\"More on Bon-Ton Stores&#39; Q2\" data-tweet=\"$BONT - More on Bon-Ton Stores&#39; Q2 https://seekingalpha.com/news/3290081-on-bon-ton-stores-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3290081-on-bon-ton-stores-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290079\" data-ts=\"1502967121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290079-alibaba-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba beats by $0.24, beats on revenue</a></h4><ul><li>Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>): Q1 EPS of $1.17 <font color='green'>beats by $0.24</font>.</li><li>Revenue of $7.41B (+56% Y/Y)&nbsp;<font color='green'>beats by $250M</font>.</li><li>Shares <font color='green'>+3.4%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/16917971-alibaba-group-announces-june-quarter-2017-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3290079\" data-linked=\"Alibaba beats by $0.24, beats on revenue\" data-tweet=\"$BABA - Alibaba beats by $0.24, beats on revenue https://seekingalpha.com/news/3290079-alibaba-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3290079-alibaba-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3290074\" data-ts=\"1502966691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSI\" target=\"_blank\">SSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3290074-on-stage-stores-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Stage Stores&#39; Q2</a></h4><ul>     <li>Stage Stores (NYSE:<a href=\"http://seekingalpha.com/symbol/SSI\" target=\"_blank\">SSI</a>) reports comparable-store sales fell 3.6% in <a href=\"https://seekingalpha.com/pr/16917942-stage-stores-reports-second-quarter-results-raises-guidance-declares-quarterly-cash-dividend\" target=\"_blank\">Q2</a>.</li>     <li>Gross margin rate decreased 70 bps to 24.6%.</li>     <li>SG&amp;A expense rate rose 150 bps to 26.7%.</li>     <li>Merchandise inventories -3.5% Q/Q to $460.41M.</li>     <li>Store count +1 Q/Q to 851.</li>     <li><b>FY2017 Guidance</b>: Comparable-store sales: -4% to -7%; Tax rate: 32% to 34%; Adjusted EPS: $0.90 to $1.35;&nbsp;Weighted average diluted shares: 28.2M; Capex: ~$40M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3290074\" data-linked=\"More on Stage Stores&#39; Q2\" data-tweet=\"$SSI - More on Stage Stores&#39; Q2 https://seekingalpha.com/news/3290074-on-stage-stores-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3290074-on-stage-stores-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:44 AM </div></div></li>","count":72,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}